The Lancet Oncology · 2018 · 244 citations · 27 references
MedicineOncologyPharmacotherapyCancer PharmacologyImmunotherapyMolecular OncologyAntibody-drug ConjugatesB Cell BiologyB-cell ResponsesCancer ImmunotherapyMultiple MyelomaAntibody-drug Conjugate AntibodiesAntibody-drug Conjugate TherapyB-cell Targeted TherapyMonoclonal Antibody TherapeuticsMultiple Myeloma TherapyMultiple Myeloma TreatmentRefractory Multiple MyelomaRelapsed Multiple Myeloma
27
International Staging System for Multiple Myeloma
Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie et al. · Journal of Clinical Oncology · 2005 · 2.9K citations
Medicine, Hematology, Oncology +14
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee, Rebecca Gardner, David Porter et al. · Blood · 2014 · 2.8K citations
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Anas Younes, Nancy L. Bartlett, John P. Leonard et al. · New England Journal of Medicine · 2010 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text